PUBLISHER: GlobalData | PRODUCT CODE: 1663574
PUBLISHER: GlobalData | PRODUCT CODE: 1663574
Tissue Sealants and Adhesives Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Wound Care Management therapeutic area.
Tissue sealants act as a physical barrier to prevent fluid and gas leakage from surgical incisions. They are used to hold internal organ flaps together, seal blood vessels after injury or surgery, or complement hemostatic agents. Available as liquid sealants, sealant-embedded patches, or flowable pastes, tissue sealants prevent leaks of blood, CSF, air, and bile. Tissue adhesives are polymers that form a thin film to bond wound edges, enabling proper healing and protecting against microbial infections.
Tissue sealants and adhesives provide microbial protection, integrate into wounds, and offer tensile strength and flexibility. They are classified into synthetic and non-synthetic types, with non-synthetic often preferred. The growing number of trauma, burn, and surgical cases drives the market for these products.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Tissue Sealants and Adhesives and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Ethicon Inc, Baxter International Inc, CR Bard Inc, B. Braun Melsungen AG, Derma Sciences Inc, Cardinal Health Inc, CryoLife Europa Ltd and Others.
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -